Kamada And Kedrion Biopharma Announce Global Collaboration For Development, Manufacturing And Distribution Of A Plasma-Derived Anti-SARS-CoV-2 (Coronavirus COVID-19) Polyclonal Immunoglobulin Product
Benzinga Newsdesk